Ocuphire Pharma company info

What does Ocuphire Pharma do?
Ocuphire Pharma (NASDAQ:OCUP) is a specialized pharmaceutical firm engaged in the development and commercialization of innovative therapies to treat various eye disorders. Based in the United States, Ocuphire Pharma focuses on advancing its portfolio of product candidates aimed at addressing unmet medical needs in ocular health, including treatments for presbyopia, diabetic retinopathy, and other eye diseases. The company's objective is to improve vision and quality of life for patients worldwide through the pursuit of novel treatment options. With a commitment to excellence in ophthalmic research, Ocuphire Pharma is dedicated to bringing forward new, efficacious solutions that can offer significant benefits over existing therapies.
Ocuphire Pharma company media
Company Snapshot

Is Ocuphire Pharma a public or private company?


How many people does Ocuphire Pharma employ?


What sector is Ocuphire Pharma in?

pie chart
Health Care

Where is the head office for Ocuphire Pharma?

location pin
Head Office
Farmington Hills, United States

What year was Ocuphire Pharma founded?

founded flag
Year Founded
What does Ocuphire Pharma specialise in?
/Eye Therapies /Clinical Development /Night Vision /Refractive Disorders /Retinal Diseases /Pharmaceutical Innovation

What are the products and/or services of Ocuphire Pharma?

Overview of Ocuphire Pharma offerings
Nyxol for the treatment of night vision disturbances and reversal of mydriasis.
APX3330 aimed at treating diabetic retinopathy and diabetic macular edema.
Formulations for the treatment of presbyopia, enhancing near vision in adults.
Development of therapies targeting retinal diseases, emphasizing on improving visual acuity.
Research on comprehensive eye health supplements for protecting against ocular disorders.
Advanced diagnostic tools for early detection and management of glaucoma and other eye conditions.

Who is in the executive team of Ocuphire Pharma?

Ocuphire Pharma leadership team
  • Mr. Richard J. Rodgers M.B.A.
    Mr. Richard J. Rodgers M.B.A.
    Interim President & Director
  • Mr. Bernhard  Hoffmann M.B.A.
    Mr. Bernhard Hoffmann M.B.A.
    Senior Vice President of Corporate Development & Operations and Secretary
  • Ms. Amy  Zaremba Rabourn C.P.A., MAcc
    Ms. Amy Zaremba Rabourn C.P.A., MAcc
    Senior Vice President of Finance
  • Mr. George  Magrath M.B.A., M.D., M.S.
    Mr. George Magrath M.B.A., M.D., M.S.
    CEO & Director
  • Mr. Nirav Suresh  Jhaveri C.F.A.
    Mr. Nirav Suresh Jhaveri C.F.A.
    Chief Financial Officer
  • Mr. Joseph K. Schachle MBA
    Mr. Joseph K. Schachle MBA
    Chief Operating Officer
  • Dr. Ashwath  Jayagopal Ph.D.
    Dr. Ashwath Jayagopal Ph.D.
    Chief Scientific & Development Officer
  • Dr. Daniela C. Oniciu Ph.D.
    Dr. Daniela C. Oniciu Ph.D.
    Global Head of R&D, Chemistry and Product Development